2
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Neoplasms
14
Lung Neoplasms
11
Breast Neoplasms
9
Colorectal Neoplasms
8
Prostatic Neoplasms
7
Stomach Neoplasms
3
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Neoplasm Metastasis
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Smoking Cessation
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic cancer, adult
2
Ovarian Neoplasms
2
Neoplastic Cells, Circulating
2
Motor Activity
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Endometrial Neoplasms
2
Disease
2
Wilms Tumor
1
Venous Thromboembolism
1
Vaginal Neoplasms
1
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
1
Testicular Germ Cell Tumor
1
Interventions
Carboplatin
8
Etoposide
7
Filgrastim
5
Bleomycin
5
Ifosfamide
4
Cisplatin
4
Thiotepa
3
Peripheral Blood Stem Cell Transplantation
3
Paclitaxel
3
Granulocyte Colony-Stimulating Factor
3
etoposide phosphate
2
Temozolomide
2
Taxes
2
Amifostine
2
sodium thiosulfate
1
ixabepilone
1
Vinblastine
1
Surgical Procedures, Operative
1
Reverse Transcriptase Polymerase Chain Reaction
1
Restraint, Physical
1
Radiotherapy
1
Psychiatric Rehabilitation
1
PT-100 dipeptide
1
Oxaliplatin
1
O(6)-benzylguanine
1
Microarray Analysis
1
Mesna
1
Melphalan
1
Immunohistochemistry
1
Hematologic Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Germ Cell Cancer
×
Hematologic Tests
×
Clear all
NCT06329323
2024-03-26
SUMMER
Imperial College London
Not yet recruiting
24 enrolled